J7212 HCPCS Level II code: Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
J7212 is the HCPCS code for “Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
Short description: Factor viia recomb sevenfact
HCPCS · United States
Medicare details
The indicators CMS publishes with J7212 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2021
Where J7212 sits
- 1J codesDrugs administered other than orally
- 2Active code J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7212 mean?
J7212 is the HCPCS code for “Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7212?
CMS lists J7212’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7212
All J codesJ7205Injection, factor viii fc fusion protein (recombinant), per iuJ7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.J7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.J7214Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.J7294Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, eachJ7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, eachJ7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mgJ7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg